PHGDH and melanoma: Interestingly, PHGDH has previously been proposed as a therapeutic target for melanoma in overcoming resistance to MEKis PD0325901 and trametinib [33,34], where suppression of PHGDH led to sensitivity in MEKi-resistant melanoma cells.